UEF and Ferring Ventures continue collaboration in gene and cell therapy research.

UEF and Ferring Ventures continue collaboration in gene and cell therapy research.

Ferring Ventures SA is the owner of both KCT Oy and FinVector Oy. The research collaboration with the University of Eastern Finland is strongly focused on the National Virus Vector Laboratory at A.I Virtanen Institute in the Faculty of Health Sciences. This scientific collaboration is in both parties’ interests, as novel research findings relying on the university’s broad and strong infrastructure can be rapidly advanced through business collaboration.

Read more

UEF and Ferring Ventures continue collaboration in gene and cell therapy research.

Ferring Ventures SA is the owner of both KCT Oy and FinVector Oy. The research collaboration with the University of Eastern Finland is strongly focused on the National Virus Vector Laboratory at A.I Virtanen Institute in the Faculty of Health Sciences. This scientific collaboration is in both parties’ interests, as novel research findings relying on the university’s broad and strong infrastructure can be rapidly advanced through business collaboration.

Development of large-scale downstream processing for lentiviral vectors.

Anniina J. Valkama, Igor Oruetxebarria, Eevi M. Lipponen, Hanna M. Leinonen, Piia Käyhty, Heidi Hynynen, Vesa Turkki, Joonas Malinen, Tuukka Miinalainen, Tommi Heikura, Nigel Parker, Seppo Ylä-Herttuala, Hanna P. Lesch. Development of large-scale downstream processing for lentiviral vectors. 2020 Mar 25; https://doi.org/10.1016/j.omtm.2020.03.025

Preclinical proof-of-concept, analytical development and commercial scale production of lentiviral vector in adherent cells.

Hanna Leinonen, Eevi Lipponen, Anniina Valkama, Heidi Hynynen, Igor Oruetxebarria, Vesa Turkki, Venla Olsson, Jere Kurkipuro, Haritha Samaranayake, Ann-Marie Määttä, Nigel Parker, Seppo Ylä-Herttuala, and Hanna Lesch. Preclinical proof-of-concept, analytical development and commercial scale production of lentiviral vector in adherent cells. 2019 Aug 29; doi: https://doi.org/10.1016/j.omtm.2019.08.006.

Temporal Dynamics of Gene Expression During Endothelial Cell Differentiation From Human iPS Cells: AComparison Study of Signalling Factors and Small Molecules.

Belt H, Koponen JK, Kekarainen T, Puttonen KA, Mäkinen PI, Niskanen H, Oja J, Wirth G, Koistinaho J, Kaikkonen MU, Ylä-Herttuala S.
Temporal Dynamics of Gene Expression During Endothelial Cell Differentiation From Human iPS Cells: A
Comparison Study of Signalling Factors and Small Molecules.
Front Cardiovasc Med. 2018 Mar 14;5:16. doi: 10.3389/fcvm.2018.00016.